ES438108A1 - Halophenylthioacetamide cephalosporin derivatives - Google Patents

Halophenylthioacetamide cephalosporin derivatives

Info

Publication number
ES438108A1
ES438108A1 ES438108A ES438108A ES438108A1 ES 438108 A1 ES438108 A1 ES 438108A1 ES 438108 A ES438108 A ES 438108A ES 438108 A ES438108 A ES 438108A ES 438108 A1 ES438108 A1 ES 438108A1
Authority
ES
Spain
Prior art keywords
hydrogen
chlorine
formula
phenyl ring
oxadiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES438108A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES438108A1 publication Critical patent/ES438108A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/4009—Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
    • C08G18/4072—Mixtures of compounds of group C08G18/63 with other macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/0061—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof characterized by the use of several polymeric components
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2483/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon only; Derivatives of such polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A process for the preparation of halofenylthiacetamidocephalosporin derivatives of the formula ** (see formula) ** Where z is hydrogen or fluorine and, when z is hydrogen, each of the symbols x and y is hydrogen or chlorine, selected so that the phenyl ring is substituted with 1 or 2 chlorine atoms and, thus, when a chlorine atom is present, it is in position 3 and, when 2 chlorine atoms are present, they are in positions 3,4, 3,5 or 2,5; When z is fluorine, it is in the 3 or 4 position of the phenyl ring and each of the symbols x and y is hydrogen or chlorine so that, when the phenyl ring is substituted with 1 or 2 chlorine atoms, one of these chlorine atoms, is in the 3 or 4 position of the phenyl ring; 5-phenyl-1,3,4-oxadiazolyl-2-thio, 1-methyl-5-tetrazolylthio, 5- (p-nitrophenyl) -1,3,4-oxadiazolyl-2-thio, 5- (p-methoxyphenyl) -1,3,4-oxadiazolyl-2-thio-thiomethyl; y R 'is hydrogen, dicyclohexylamine or a pharmaceutically acceptable cation; Whose process is characterized by reacting a compound of formula: ** (see formula) ** Where x, y, z and r 'are those defined above, with a thiol of formula hr where r is as defined above. (Machine-translation by Google Translate, not legally binding)
ES438108A 1971-12-27 1975-05-31 Halophenylthioacetamide cephalosporin derivatives Expired ES438108A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21273971A 1971-12-27 1971-12-27
US28822772A 1972-09-11 1972-09-11

Publications (1)

Publication Number Publication Date
ES438108A1 true ES438108A1 (en) 1977-05-16

Family

ID=26907406

Family Applications (2)

Application Number Title Priority Date Filing Date
ES410249A Expired ES410249A1 (en) 1971-12-27 1972-12-27 Halophenylthioacetamide cephalosporin derivatives
ES438108A Expired ES438108A1 (en) 1971-12-27 1975-05-31 Halophenylthioacetamide cephalosporin derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES410249A Expired ES410249A1 (en) 1971-12-27 1972-12-27 Halophenylthioacetamide cephalosporin derivatives

Country Status (17)

Country Link
JP (1) JPS4885593A (en)
AR (1) AR201736A1 (en)
AT (2) AT325202B (en)
BE (1) BE793311A (en)
CA (1) CA1017325A (en)
CH (2) CH555365A (en)
DE (1) DE2263439C2 (en)
ES (2) ES410249A1 (en)
FR (1) FR2166081A1 (en)
GB (1) GB1405797A (en)
HU (1) HU166211B (en)
IE (1) IE37029B1 (en)
IL (1) IL41162A (en)
NL (1) NL7217698A (en)
PH (1) PH9252A (en)
SE (1) SE417208B (en)
YU (1) YU37494B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329363B1 (en) 1997-12-12 2001-12-11 Eli Lilly And Company Cephalosporin antibiotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1321704A (en) * 1962-04-03 1963-03-22 Lilly Co Eli Process for preparing 7- (s-substituted mercapto-acylamido) derivatives of cephalosporins c and novel compounds thus prepared
US3335136A (en) * 1965-12-27 1967-08-08 Lilly Co Eli Halophenylmercaptomethyl cephalosporins
JPS4849789A (en) * 1971-10-25 1973-07-13

Also Published As

Publication number Publication date
IE37029L (en) 1973-06-27
IE37029B1 (en) 1977-04-13
ATA161374A (en) 1975-02-15
FR2166081A1 (en) 1973-08-10
BE793311A (en) 1973-06-27
AT326269B (en) 1975-12-10
CH581662A5 (en) 1976-11-15
DE2263439C2 (en) 1984-07-19
IL41162A0 (en) 1973-02-28
YU37494B (en) 1984-08-31
YU324572A (en) 1981-08-31
JPS4885593A (en) 1973-11-13
GB1405797A (en) 1975-09-10
CA1017325A (en) 1977-09-13
AT325202B (en) 1975-10-10
AR201736A1 (en) 1975-04-15
SE417208B (en) 1981-03-02
IL41162A (en) 1975-08-31
ES410249A1 (en) 1976-04-01
HU166211B (en) 1975-02-28
DE2263439A1 (en) 1973-07-12
FR2166081B1 (en) 1976-04-23
CH555365A (en) 1974-10-31
PH9252A (en) 1975-07-30
NL7217698A (en) 1973-06-29

Similar Documents

Publication Publication Date Title
ES438108A1 (en) Halophenylthioacetamide cephalosporin derivatives
ES404745A1 (en) Cephalosporin compounds
ES432334A1 (en) 11 amidoarukiru 44 suruhoniruupiperajinkagobutsunoseizoho
ES399003A1 (en) 2-aryl-amino-imidazoline-2 compounds
ES449777A1 (en) Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them
GB1175617A (en) Substituted Pteridine Derivatives
ES410248A1 (en) Halogenated phenylthioacetamide cephalosporanic acids
ES435351A1 (en) 1-(3-phenylpropyl)-4-furoylpiperazine derivatives
ES398868A1 (en) Process for the preparation of derivatives of 1,2-diphenyl-3,5- dioxo-4-n-butylpyrazolidine
ES462843A1 (en) Compound and production thereof
ES286808A1 (en) A procedure for the preparation of benzoxazepin derivatives (Machine-translation by Google Translate, not legally binding)
ES481135A1 (en) Cephalosporins and pharmaceutical compositions containing them.
ES405281A1 (en) Cephalosporin compounds
ES416029A1 (en) Procedure for producing s-substitute 2-thioadenosins and their derivatives. (Machine-translation by Google Translate, not legally binding)
ES401892A1 (en) Procedure for the preparation of new benzodiacepine compounds. (Machine-translation by Google Translate, not legally binding)
ES425046A1 (en) Thiazolotriazolylphosphorothioates and the preparation and uses thereof
ES322716A1 (en) Method for the production of an anticolinergic compound. (Machine-translation by Google Translate, not legally binding)
ES306910A1 (en) Procedure for the production of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
ES409594A1 (en) Iso-indolinone derivative
ES458846A1 (en) A procedure for the preparation of new cephalosporins. (Machine-translation by Google Translate, not legally binding)
ES478822A1 (en) Procedure for the preparation of derivatives substituted of 2-chloronicotinamidas. (Machine-translation by Google Translate, not legally binding)
ES407018A1 (en) Dialkylsulfoximinocarbonylmethyl thiophosphates and process for preparation thereof
ES432775A1 (en) 7-(alpha-(guanyl-1-ureido)phenylacetamido)3-substituted cephalosporin antibiotics
ES388250A1 (en) A procedure for preparing pirazolo-piridincarboxilico acid compounds. (Machine-translation by Google Translate, not legally binding)
ES391036A1 (en) A procedure for the preparation of N-substituted derivatives of compounds of 14-hydroxydehydronormorfin. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202